NOVEMBER 2-4, 2026 | BETHESDA NORTH MARRIOTT HOTEL & CONFERENCE CENTER, ROCKVILLE, MD

EXPLORE SCIENTIFIC ADVANCES FROM GENERICS AND BIOSIMILARS

GRx+Biosims™ 2026 is the leading regulatory, science and policy event for the U.S. generics and biosimilars industry. Access timely information straight from U.S. regulatory experts, grasp the latest policies shaping the industry, and acquire valuable insights to propel your professional development.

BE INFORMED +
GAIN INSIGHTS

Bench scientists and technical professionals can gain insights from drug regulators to help expedite approvals and speed to market; and learn about the latest innovations and emerging technologies. Policy professionals, industry professionals and regulators have the opportunity to network with others in the industry and gain a deeper understanding of how regulations affect the real world. In addition, attendees can connect with global influencers to increase their knowledge base and stay on the cutting edge, while honing best practices to enhance overall professional and organizational performance.

GRx+Biosims 2024, Rockville, MD

CONNECT + ENGAGE

Join us at GRx+Biosims 2025 on October 27–29, 2025. This conference offers three days of networking opportunities and thought-provoking discussions on key issues impacting the generics and biosimilars industry. Our program is designed to inspire and inform— featuring insights from industry leaders and experts.

Why You Should Attend

Network with speakers, attendees, exhibitors and sponsors

Get access to the latest information about U.S. generics and biosimilars

Learn how legislation related to the generics and biosimilars industry can impact patient access to more affordable medicines

Gain expert insights on implementation of the latest regulations, guidances, case law, current health authority processes and practices, and policy

Make more informed decisions by better understanding the FDA’s expectations and current thinking on processes, practice and policy

Attend this one-stop-shop for all your U.S. generics and biosimilars industry policy, regulatory and scientific needs

Speaker Highlights

Henri Akouka

Director, Combination Product & Device, Biopharmaceutical Development and Engineering
Teva Pharmaceuticals

Denis Arsenault

Manager, Policy Development
Health Canada

Dinakaran Balasubramanian

Head of Commercial Strategy
Dr. Reddy's Laboratories, Inc.

Michael Balon

Senior Director, Global Regulatory Affairs
Apotex Inc.

Yanira Gonzalez-Berrios, PhD

Senior Chemist, DPQAVII, OPQAII, OPQ
FDA

SHOWCASE YOUR COMPANY

Don’t miss out on this highly interactive and professional business environment, where industry vendors can meet face-to-face with key industry executives. We offer our exhibitors abundant networking time with industry decision-makers. To learn more, email Aquera Agee.

GRX+BIOSIMS 2025
SOCIAL MEDIA TOOLKIT

STAY INFORMED WITH THE MOST RECENT UPDATES

Access up-to-date event details, including information about prominent speakers, sponsorship options, and exhibition opportunities.